Technologies

We have identified compounds that show a neuroprotective action in vivo, in models of neurodegenerative diseases (e.g. SMA, Parkinson, Alzheimer, Huntington) in the model organism C. elegans. These compounds consist of: mixtures of 22 natural extracts, 15 natural molecules and 11 synthetic molecules.

Plants can compete favorably with traditional expression systems (mammalian cells, yeasts or bacteria) to produce recombinant proteins/peptides of pharmaceutical/industrial/agrifood interest. This technology names “Plant Molecular Farming”. The CNR-IBBA research team offers the study of new strategies for the expression and optimization of recombinant proteins/peptides in plant-based systems (plant tissues, transgenic plants, plant cell culture). Our pipeline is based on the following modules:

The technology is intended to face the main problems of transmucosal dental implants, such as peri-implant mucositis, peri-implantitis and epithelial downgrowth. The strategy foresees the development of a surface able to favor soft tissues growth (gum sealing), limit at the implant collar these tissues, reduce bacterial adhesion and eventually have an antibacterial action.